文献速递脑血管病

韩国糖尿病前期成人血管病死亡风险增加主要归因于缺血性卒中

Increased Vascular Disease Mortality Risk in Prediabetic Korean Adults Is Mainly Attributable to Ischemic Stroke.
PubMed 文献 · Stroke · 2017-03-03

该全国队列研究纳入韩国国民健康保险服务2002-2013年数据,按空腹血糖分层为正常糖耐量、空腹血糖受损(IFG)1期、2期和糖尿病。结果显示IFG 2期与全因死亡和血管病死亡风险升高相关,血管病死亡风险主要归因于缺血性卒中而非缺血性心脏病或出血性卒中。

要点

  • IFG 2期(空腹血糖110-125 mg/dL)与全因死亡和血管病死亡风险显著升高相关。
  • IFG 2期血管病死亡风险升高主要归因于缺血性卒中。
  • IFG 1期(100-109 mg/dL)未显示与死亡风险显著相关。

核心结论

  • 较高程度IFG(空腹血糖110-125 mg/dL)与全因死亡和血管病死亡风险增加相关。
  • IFG 2期血管病死亡风险增加归因于缺血性卒中,而非缺血性心脏病或出血性卒中。

研究设计与样本

  • 韩国国民健康保险服务2002-2013年全国队列研究。
  • 按空腹血糖分层为正常糖耐量(<100 mg/dL)、IFG 1期(100-109 mg/dL)、IFG 2期(110-125 mg/dL)和糖尿病。
  • 采用计数过程公式的Cox回归分析评估血管病及其亚型死亡风险。

主要发现

  • 调整年龄、性别和体重指数后,IFG 2期全因死亡HR为1.26(95%CI 1.18-1.34),血管病死亡HR为1.27(95%CI 1.08-1.49)。
  • IFG 2期缺血性卒中死亡HR为1.60(95%CI 1.18-2.18),缺血性心脏病和出血性卒中死亡风险未显著升高。
  • 调整其他可改变血管病危险因素后,IFG 2期缺血性卒中死亡HR为1.51(95%CI 1.10-2.09)。
  • 调整医疗治疗后,IFG 2期缺血性卒中死亡HR为1.75(95%CI 1.19-2.57)。
  • IFG 1期未显示与全因死亡或血管病死亡风险显著相关。

临床怎么用

  • 对IFG 2期(空腹血糖110-125 mg/dL)成人应关注缺血性卒中死亡风险升高。
  • IFG 2期血管病死亡风险增加主要归因于缺血性卒中,而非缺血性心脏病或出血性卒中。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Prediabetes is a known risk factor for vascular diseases; however, its differential contribution to mortality risk from various vascular disease subtypes is not known. METHODS: The subjects of the National Health Insurance Service in Korea (2002-2013) nationwide cohort were stratified into normal glucose tolerance (fasting glucose <100 mg/dL), impaired fasting glucose (IFG) stage 1 (100-109 mg/dL), IFG stage 2 (110-125 mg/dL), and diabetes mellitus groups based on the fasting glucose level. A Cox regression analysis with counting process formulation was used to assess the mortality risk for vascular disease and its subtypes-ischemic heart disease, ischemic stroke, and hemorrhagic stroke. RESULTS: When adjusted for age, sex, and body mass index, IFG stage 2, but not stage 1, was associated with significantly higher all-cause mortality (hazard ratio [HR], 1.26; 95% confidence interval [CI], 1.18-1.34) and vascular disease mortality (HR, 1.27; 95% CI, 1.08-1.49) compared with normal glucose tolerance. Among the vascular disease subtypes, mortality from ischemic stroke was significantly higher (HR, 1.60; 95% CI, 1.18-2.18) in subjects with IFG stage 2 but not from ischemic heart disease and hemorrhagic stroke. The ischemic stroke mortality associated with IFG stage 2 remained significantly high when adjusted other modifiable vascular disease risk factors (HR, 1.51; 95% CI: 1.10-2.09) and medical treatments (HR, 1.75; 95% CI, 1.19-2.57). CONCLUSIONS: Higher IFG degree (fasting glucose, 110-125 mg/dL) was associated with increased all-cause and vascular disease mortality. The increased vascular disease mortality in IFG stage 2 was attributable to ischemic stroke, but not ischemic heart disease or hemorrhagic stroke in Korean adults.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Kim NH, Kwon TY, Yu S, et al. Increased Vascular Disease Mortality Risk in Prediabetic Korean Adults Is Mainly Attributable to Ischemic Stroke. Stroke. 2017. PMID: 28258257. doi:10.1161/STROKEAHA.116.015947

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。